Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
171.4 BRL | -2.16% | -.--% | -16.49% |
01:00pm | US FDA advisers to review Eli Lilly Alzheimer's drug | RE |
09:44am | Biogen, Eisai Say Alzheimer's Maintenance Treatment Application Accepted by US FDA | MT |
Performance
1 day | -2.16% | ||
3 months | -4.61% | ||
6 months | -12.39% | ||
Current year | -16.49% | ||
1 year | -31.95% | ||
3 years | -50.17% | ||
5 years | +16.08% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Biopharmaceuticals
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-2.16% | -.--% | -16.49% | -31.95% | 32.82B | ||
-0.17% | +3.18% | +0.82% | -5.34% | 91.94B | ||
-1.32% | +2.74% | -1.32% | -6.37% | 38.74B | ||
-0.19% | +1.61% | +64.45% | +52.68% | 26.66B | ||
-0.20% | +7.49% | -16.31% | -11.69% | 15.32B | ||
+0.44% | -2.26% | -11.38% | +0.20% | 11.65B | ||
+13.03% | +44.70% | +173.10% | +471.13% | 10.37B | ||
-1.29% | -6.55% | -49.84% | -31.01% | 10.12B | ||
-0.75% | -1.48% | +4.42% | +27.89% | 9.06B | ||
+0.14% | +1.70% | -16.26% | -4.91% | 7.46B | ||
-0.20% | +1.74% | -4.48% | +3.93% | 7.22B | ||
-0.38% | +10.06% | +0.81% | +20.42% | 7.09B | ||
+1.50% | +4.65% | -7.12% | +4.94% | 6.77B | ||
-2.12% | -5.08% | -40.96% | -19.22% | 6.14B | ||
-0.26% | -3.43% | -32.99% | +69.06% | 5.06B | ||
-1.66% | +2.85% | -32.56% | -55.15% | 4.9B | ||
Average | +0.28% | +4.46% | +0.87% | +30.29% | ||
Weighted average by Cap. | -0.14% | +4.05% | +4.72% | +15.09% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | -16.49% | ||
2023 | -14.50% | ||
2022 | +8.77% | ||
2021 | +4.72% | ||
2020 | +3.96% | ||
2019 | +6.09% | ||
2018 | +7.66% | ||
2017 | +12.34% | ||
2016 | -5.91% |
- Stock Market
- Equities
- BIIB Stock
- BIIB34 Stock
- Quotes Biogen Inc.